Suchergebnisse - "Sarilumab"

PubPharm (15)

1

Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

enthalten in: Journal of managed care & specialty pharmacy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

2

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

3

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate : results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis research & therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

ErratumIn: Arthritis Res Ther. 2019 Apr 16;21(1):99. - PMID 30992058

4

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression : 5 years of sarilumab plus methotrexate treatment

enthalten in: RMD open | 2019

von Genovese, M. | van der Heijde, D. | Lin, Y. | +9

5

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX : safety, efficacy and radiographic outcomes

enthalten in: Rheumatology (Oxford, England) | 2018

von Genovese, M. | van Adelsberg, J. | Fan, C. | +8

6

Sarilumab : A Review in Moderate to Severe Rheumatoid Arthritis

enthalten in: Drugs | 2018

von Lamb, Y. | Deeks, E.

7

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2018

von Strand, V. | Gossec, L. | Proudfoot, C. | +9

8

Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2018

von Bae, S. | Lee, Y.

9

A review of sarilumab for the treatment of rheumatoid arthritis

enthalten in: Immunotherapy | 2018

von Lee, E.

10

Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH) : a randomised, double-blind, parallel-group phase III trial

enthalten in: Annals of the rheumatic diseases | 2017

von Burmester, G. | Lin, Y. | Patel, R. | +7